Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
García, R
Pérez, P
Alfonso, R
Pérez-Manga, G
Díaz-Rubio, E
机构：
[1] Hosp Gen Gregorio Maranon, Madrid, Spain
[2] H Clin San Carlos, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
528P
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] Weekly docetaxel and vinorelbine as second-line therapy in advanced non-small cell lung cancer
    Huber, R
    Schmidt, M
    Borgmeier, A
    [J]. LUNG CANCER, 2005, 49 : S248 - S248
  • [2] Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
    J. Feliu
    G. Martín
    J. Castro
    A. Sundlov
    A. Rodriguez-Jaráiz
    E. Casado
    M. Lomas
    C. Madroñal
    A. Galán
    C. Belda
    M. Gonzalez-Barón
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58 : 527 - 531
  • [3] Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
    Feliu, J.
    Martin, G.
    Castro, J.
    Sundlov, A.
    Rodriguez-Jaraiz, A.
    Casado, E.
    Lomas, M.
    Madronal, C.
    Galan, A.
    Belda, C.
    Gonzalez-Baron, M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 527 - 531
  • [4] Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Ardizzoni, A
    Tiseo, M
    [J]. JOURNAL OF CHEMOTHERAPY, 2004, 16 : 104 - 107
  • [5] Docetaxel as Second-line Monotherapy for Advanced Non-small Cell Lung Cancer
    Kang, Hyun Mo
    Lee, Jeong Eun
    Jang, Pil Soon
    Lee, Yun Sun
    Kwon, Sun Jung
    An, Jin Young
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 58 (05) : 465 - 472
  • [6] Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: Phase II trial
    Serke, M
    Schoenfeld, N
    Loddenkemper, R
    [J]. ANTICANCER RESEARCH, 2004, 24 (2C) : 1211 - 1216
  • [7] Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer
    Pesek, M
    Holá, V
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 155 - 160
  • [8] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [9] Weekly docetaxel (D) as second line therapy in advanced non small cell lung cancer (NSCLC)
    Valerio, M. R.
    Vizzini, L.
    Intrivici, C.
    Spinnato, F.
    Di Fede, G.
    Rinaldi, G.
    Benfante, B.
    Russo, A.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 165 - 165
  • [10] A pilot study of weekly docetaxel and daily trofosfamide as metronomic second-line chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC)
    Gorn, M.
    Habermann, C.
    Thom, I.
    Schuch, G.
    Andritzky, B.
    Brandl, S.
    Burkholder, I.
    Hossfeld, D. K.
    Bokemeyer, C.
    Laack, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345